Herbert Irving Comprehensive Cancer Center

New York, New York 10032

Use our guide to learn which trials are right for you!

We've found
4 trials
at this facility
Oncology, Reproductive Clinical Trial
HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Neurology, Oncology Clinical Trial
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Status: Enrolling, Phase II
Updated: 6/30/2015
Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Trial
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent and Smoldering Systemic Mastocytosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Herbert Irving Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials